Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

TSHR – athyreosis

Pathogenic variants in the thyrotropin receptor gene (TSHR) have been implicated in a subset of congenital hypothyroidism due to athyreosis. In a cohort of 100 Chinese patients with congenital hypothyroidism and athyreosis, seven unrelated probands harbored heterozygous missense TSHR variants, including c.491T>A (p.Met164Lys) (7 probands ([PMID:28455095])). All identified changes were missense substitutions without accompanying family segregation data. No functional assays were performed to validate these variants in the context of thyroid dysgenesis. Consequently, the current association is supported solely by variant discovery in affected individuals. Overall, evidence for a causative role of TSHR in athyreosis remains limited.

Key take-home: TSHR sequencing can identify rare missense variants in a small fraction of congenital athyreosis cases, aiding molecular diagnosis.

References

  • Clinica chimica acta; international journal of clinical chemistry • 2017 • Next-generation sequencing of NKX2.1, FOXE1, PAX8, NKX2.5, and TSHR in 100 Chinese patients with congenital hypothyroidism and athyreosis. PMID:28455095

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

7 probands with TSHR variants in congenital hypothyroidism and athyreosis ([PMID:28455095]); no segregation or disease-specific functional validation

Genetic Evidence

Limited

7 missense variants identified in unrelated probands ([PMID:28455095]); absence of familial segregation

Functional Evidence

Not applicable

No functional studies of TSHR variants in athyreosis; existing assays pertain to other thyroid phenotypes